Nanalysis Scientific Corp.
OTC:NSCIF
0.3189 (USD) • At close November 15, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 28.466 | 24.821 | 16.043 | 7.874 | 8.364 | 8.381 | 7.668 | 5.252 |
| Cost of Revenue
| 28.908 | 13.682 | 5.803 | 2.707 | 2.304 | 2.983 | 2.774 | 2.147 |
| Gross Profit
| -0.442 | 11.139 | 10.24 | 5.167 | 6.06 | 5.398 | 4.895 | 3.105 |
| Gross Profit Ratio
| -0.016 | 0.449 | 0.638 | 0.656 | 0.725 | 0.644 | 0.638 | 0.591 |
| Reseach & Development Expenses
| 0.679 | 1.465 | 0.643 | 0.476 | 0.27 | 0.166 | 0 | 0 |
| General & Administrative Expenses
| 11.041 | 12.665 | 6.14 | 3.512 | 2.766 | 2.256 | 1.315 | 1.325 |
| Selling & Marketing Expenses
| 1.352 | 2.355 | 2.143 | 3.239 | 2.453 | 2.515 | 1.96 | 1.566 |
| SG&A
| 12.414 | 15.02 | 8.283 | 6.751 | 5.219 | 4.771 | 0.173 | 0.025 |
| Other Expenses
| 4.413 | 4.564 | 2.505 | 1.681 | 0.775 | 0 | 0 | 0 |
| Operating Expenses
| 13.093 | 21.049 | 11.431 | 8.908 | 5.994 | 5.11 | 0.173 | 0.025 |
| Operating Income
| -13.535 | -9.497 | -0.608 | -3.179 | 1.59 | 0.323 | -0.173 | -0.025 |
| Operating Income Ratio
| -0.475 | -0.383 | -0.038 | -0.404 | 0.19 | 0.039 | -0.023 | -0.005 |
| Total Other Income Expenses Net
| -2.733 | -0.902 | -1.164 | -0.796 | -2.989 | -0.035 | 0.001 | -0 |
| Income Before Tax
| -16.268 | -10.399 | -1.772 | -3.975 | -1.399 | 0.136 | -0.172 | -0.025 |
| Income Before Tax Ratio
| -0.571 | -0.419 | -0.11 | -0.505 | -0.167 | 0.016 | -0.022 | -0.005 |
| Income Tax Expense
| -0.011 | -0.484 | 0.581 | -0.297 | 0.261 | 0.062 | 0.21 | 0.143 |
| Net Income
| -16.196 | -9.915 | -2.353 | -3.678 | -1.66 | 0.074 | -0.172 | -0.025 |
| Net Income Ratio
| -0.569 | -0.399 | -0.147 | -0.467 | -0.198 | 0.009 | -0.022 | -0.005 |
| EPS
| -0.16 | -0.11 | -0.033 | -0.056 | -0.03 | 0.001 | -0.17 | -0.025 |
| EPS Diluted
| -0.16 | -0.11 | -0.033 | -0.056 | -0.03 | 0.001 | -0.17 | -0.025 |
| EBITDA
| -8.869 | -4.848 | 1.959 | -1.409 | 2.435 | 0.695 | -0.173 | -0.025 |
| EBITDA Ratio
| -0.312 | -0.195 | 0.122 | -0.179 | 0.291 | 0.083 | -0.023 | -0.005 |